In this tumor type, PD-L1 expression is increased by PI3K/Akt/mTOR activation mediated by either Phosphatase and tensin homolog (PTEN) inactivation or loss, or mTOR activation [28,46,47]. This evidence concerns the gene PTEN and neoplasm.